BCYRN1 and colorectal carcinoma: To understand the effects of the BCYRN1/miR-204-3p/KRAS axis on CRC progression, we designed a series of rescue experiments using miR-204-3p inhibitor, sh-KRAS and sh-BCYRN1 in LoVo and SW480 cells.